Net profit of Titan Biotech rose 15.82% to Rs 7.76 crore in the quarter ended September 2025 as against Rs 6.70 crore during the previous quarter ended September 2024. Sales rose 36.25% to Rs 54.35 crore in the quarter ended September 2025 as against Rs 39.89 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 54.35 | 39.89 | 36 |
| OPM % | 17.17 | 19.45 | - |
| PBDT | 10.43 | 7.81 | 34 |
| PBT | 9.22 | 6.72 | 37 |
| NP | 7.76 | 6.70 | 16 |